Top of the page

Laffort Mannostab Liquid 200 (10L)

Item No. MANNOSTAB10
Specific yeast cell wall mannoprotein (MP40), naturally present in wines, with the unique property of inhibiting potassium bitartrate crystallization. Patent n°2726284. MANNOSTAB™ LIQUIDE 200 is a targeted enological treatment, based on the inhibition of potassium bitartrate crystallization. It
Price $1130.1
Per Each
Excl. Tax
Each

Description

Specific yeast cell wall mannoprotein (MP40), naturally present in wines, with the unique property of inhibiting potassium bitartrate crystallization. Patent n°2726284.

MANNOSTABâ„¢ LIQUIDE 200 is a targeted enological treatment, based on the inhibition of potassium bitartrate crystallization.

It provides a natural, simple solution to the stability requirements of filtered or non-filtered wines.

• A natural constituent already present in wines, MANNOSTAB™ LIQUIDE 200 perfectly conserves the quality of the wine.

• Involving no waste materials, no energy or water consumption, MANNOSTAB™ LIQUIDE 200 is a responsible treatment which complies with new environmental constraints.

DOSAGE:

The average dosages (between 50 and 150 mL/hL) are determined by stability tests in order to prevent any risks of overdose. Two stability tests can be implemented:

• The cold test, easy to implement in wineries.

• The mini-contact test, realised in laboratory (DIT, Stabilab® – Patent Eurodia)

Specifications

Brand
Laffort

Laffort Mannostab Liquid 200 (10L)

Item No. MANNOSTAB10
Specific yeast cell wall mannoprotein (MP40), naturally present in wines, with the unique property of inhibiting potassium bitartrate crystallization. Patent n°2726284. MANNOSTAB™ LIQUIDE 200 is a targeted enological treatment, based on the inhibition of potassium bitartrate crystallization. It
Price $1130.1
Per Each
Excl. Tax
Each

Description

Specific yeast cell wall mannoprotein (MP40), naturally present in wines, with the unique property of inhibiting potassium bitartrate crystallization. Patent n°2726284.

MANNOSTABâ„¢ LIQUIDE 200 is a targeted enological treatment, based on the inhibition of potassium bitartrate crystallization.

It provides a natural, simple solution to the stability requirements of filtered or non-filtered wines.

• A natural constituent already present in wines, MANNOSTAB™ LIQUIDE 200 perfectly conserves the quality of the wine.

• Involving no waste materials, no energy or water consumption, MANNOSTAB™ LIQUIDE 200 is a responsible treatment which complies with new environmental constraints.

DOSAGE:

The average dosages (between 50 and 150 mL/hL) are determined by stability tests in order to prevent any risks of overdose. Two stability tests can be implemented:

• The cold test, easy to implement in wineries.

• The mini-contact test, realised in laboratory (DIT, Stabilab® – Patent Eurodia)

Specifications

Brand
Laffort